For this purpose, we performed in a collective of OSCC a clinical data collection as well as immunohistochemical staining of some of the most important tumor-infiltrating immune cells, i.e., CD4+, CD8+, and FoxP3+ T-cells as well as CD1a+ DCs. This evidence concerns the gene CD1A and neoplasm.